Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$1.36 - $3.65 $14,728 - $39,529
-10,830 Reduced 42.71%
14,530 $19,000
Q1 2024

Apr 22, 2024

BUY
$3.52 - $9.59 $16,114 - $43,903
4,578 Added 22.03%
25,360 $95,000
Q4 2023

Jan 16, 2024

BUY
$5.97 - $10.36 $48,762 - $84,620
8,168 Added 64.75%
20,782 $203,000
Q3 2023

Oct 24, 2023

BUY
$8.23 - $13.93 $103,813 - $175,713
12,614 New
12,614 $105,000
Q3 2021

Nov 02, 2021

SELL
$24.86 - $35.02 $187,842 - $264,611
-7,556 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$22.3 - $36.02 $110,318 - $178,190
-4,947 Reduced 39.57%
7,556 $264,000
Q1 2021

May 14, 2021

BUY
$26.38 - $51.15 $329,829 - $639,528
12,503 New
12,503 $416,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.